Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0542 Transporter Info
Gene Name	ANXA2
Transporter Name	Annexin A2
Gene ID	302
UniProt ID	P07355

Post-Translational Modification of This DT
Overview of ANXA2 Modification Sites with Functional and Structural Information
Sequence	M S T V H E I L C K L S L E G D H S T P P S A Y G S V K A Y T N F D A E R D A L N I E T A I K T K G V D E V T I V N I L T N R S N A Q R Q D I A F A Y Q R R T K K E L A S A L K S A L S G H L E T V I L G L L K T P A Q Y D A S E L K A S M K G L G T D E D S L I E I I C S R T N Q E L Q E I N R V Y K E M Y K T D L E K D I I S D T S G D F R K L M V A L A K G R R A E D G S V I D Y E L I D Q D A R D L Y D A G V K R K G T D V P K W I S I M T E R S V P H L Q K V F D R Y K S Y S P Y D M L E S I R K E V K G D L E N A F L N L V Q C I Q N K P L Y F A D R L Y D S M K G K G T R D K V L I R I M V S R S E V D M L K I R S E F K R K Y G K S L Y Y Y I Q Q D T K G D Y Q K A L L Y L C G G D D
PTM type	X-Acetylation X-Glutathionylation X-Malonylation X-Methylation X-O-glycosylation X-Oxidation X-Phosphorylation X-S-glutathionylation X-S-nitrosylation X-S-palmitoylation X-S-sulfhydration X-Succinylation X-Sulfoxidation X-SUMOylation X-Ubiquitination X: Amino Acid

Acetylation
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	175
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Alanine 175 has the potential to affect its expression or activity.
Arginine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	245
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Arginine 245 has the potential to affect its expression or activity.
Asparticacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	166
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Asparticacid 166 has the potential to affect its expression or activity.
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Cystine 133 has the potential to affect its expression or activity.
Glutamicacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	297
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Glutamicacid 297 has the potential to affect its expression or activity.
Glutamine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Glutamine	Modified Location	320
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Glutamine 320 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	122
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Glycine 122 has the potential to affect its expression or activity.
Leucine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	170
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Leucine 170 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	331
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Leucine 331 has the potential to affect its expression or activity.
Lysine	22 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	10
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 10 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	28
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 28 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	47
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 47 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	49
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 49 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA2			[1] , [5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	104
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 104 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA2			[2] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	115
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 115 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA2			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	119
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 119 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ANXA2			[2] , [7]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	148
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 148 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ANXA2			[2] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	152
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 152 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ANXA2			[2] , [4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	157
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 157 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ANXA2			[4] , [8]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	176
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 176 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ANXA2			[2] , [4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	204
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 204 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ANXA2			[2] , [4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	212
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 212 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ANXA2			[2] , [7]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	227
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 227 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ANXA2			[2] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	233
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 233 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ANXA2			[4] , [9]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	266
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 266 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence ANXA2			[2] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	279
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 279 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence ANXA2			[2] , [7]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	302
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 302 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence ANXA2			[10]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	310
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 310 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence ANXA2			[2] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	313
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 313 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence ANXA2			[2] , [6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	324
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 324 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence ANXA2			[2] , [4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	329
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at ANXA2 Lysine 329 has the potential to affect its expression or activity.
Glutathionylation
Cystine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	Glutathionylation at ANXA2 Cystine 9 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[11] , [13]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	Glutathionylation at ANXA2 Cystine 133 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[12]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	262
Experimental Method	Co-Immunoprecipitation
Detailed Description	Glutathionylation at ANXA2 Cystine 262 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[12]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	335
Experimental Method	Co-Immunoprecipitation
Detailed Description	Glutathionylation at ANXA2 Cystine 335 has the potential to affect its expression or activity.
Malonylation
Lysine	11 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	80
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 80 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	81
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 81 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	119
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 119 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	148
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 148 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	152
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 152 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	169
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 169 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	176
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 176 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	233
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 233 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	279
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 279 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	310
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 310 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ANXA2			[14]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	313
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at ANXA2 Lysine 313 has the potential to affect its expression or activity.
Methylation
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	227
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at ANXA2 Lysine 227 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	313
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at ANXA2 Lysine 313 has the potential to affect its expression or activity.
O-glycosylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	2
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at ANXA2 Serine 2 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	153
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at ANXA2 Threonine 153 has the potential to affect its expression or activity.
Oxidation
Cysteine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[17]
Role of PTM	Potential impacts
Modified Residue	Cysteine	Modified Location	208
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ANXA2 Cysteine 208 has the potential to affect its expression or activity.
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ANXA2 Cystine 133 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[17]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	262
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at ANXA2 Cystine 262 has the potential to affect its expression or activity.
Phosphorylation
Arginine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	37
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Arginine 37 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	145
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Arginine 145 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	179
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Arginine 179 has the potential to affect its expression or activity.
Asparticacid	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[21]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	16
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Asparticacid 16 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	110
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Asparticacid 110 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	182
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Asparticacid 182 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	239
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Asparticacid 239 has the potential to affect its expression or activity.
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[19]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	335
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Cystine 335 has the potential to affect its expression or activity.
Glutamicacid	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[19]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	36
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Glutamicacid 36 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	130
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Glutamicacid 130 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[22]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	253
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Glutamicacid 253 has the potential to affect its expression or activity.
Glycine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	202
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Glycine 202 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	336
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Glycine 336 has the potential to affect its expression or activity.
Isoleucine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	42
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Isoleucine 42 has the potential to affect its expression or activity.
Leucine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	40
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Leucine 40 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	103
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Leucine 103 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	252
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Leucine 252 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	332
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Leucine 332 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA2			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	334
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Leucine 334 has the potential to affect its expression or activity.
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	49
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Lysine 49 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[19] , [22]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	206
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Lysine 206 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	233
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Lysine 233 has the potential to affect its expression or activity.
Phenylalanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	256
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Phenylalanine 256 has the potential to affect its expression or activity.
Serine	26 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Stabilises a protein conformation			[23]
Role of PTM	Protein Stability
Affected Drug/Substrate	Calcium-dependent lipid	Results for Drug	Affecting the inward transport of calcium-dependent lipid
Modified Residue	Serine	Modified Location	25
Modified State	Serine to Glutamicacid mutation
Related Enzyme	Tyrosine-protein kinase CSK (CSK)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at ANXA2 Serine 25 (i.e. Serine to Glutamicacid mutation) have been reported to stabilize its protein conformation .
PTM Phenomenon 2	No significant effect			[23]
Role of PTM	No Significant Effect
Affected Drug/Substrate	Calcium-dependent lipid	Results for Drug	Affecting the inward transport of calcium-dependent lipid
Modified Residue	Serine	Modified Location	11
Modified State	Serine to Asparticacid/Glutamicacid mutation
Related Enzyme	Tyrosine-protein kinase CSK (CSK)
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at ANXA2 Serine 11 (i.e. Serine to Asparticacid/Glutamicacid mutation) have been reported to have no significant alteration in its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	2
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 2 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[24] , [25]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	12
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 12 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA2			[24] , [26]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 18 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA2			[24] , [27]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	22
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 22 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA2			[24]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	26
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 26 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ANXA2			[28] , [29]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	85
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 85 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ANXA2			[30] , [31]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	89
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 89 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ANXA2			[30]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	92
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 92 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ANXA2			[32]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	112
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 112 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ANXA2			[33]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	117
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 117 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ANXA2			[26] , [34]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	127
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 127 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ANXA2			[35]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	134
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 134 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ANXA2			[28]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	161
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 161 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ANXA2			[28] , [34]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	164
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 164 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence ANXA2			[26] , [34]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	184
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 184 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence ANXA2			[30] , [36]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	215
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 215 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence ANXA2			[28]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	221
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 221 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence ANXA2			[37]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	234
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 234 has the potential to affect its expression or activity.
PTM Phenomenon 21	Have the potential to influence ANXA2			[30] , [38]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	236
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 236 has the potential to affect its expression or activity.
PTM Phenomenon 22	Have the potential to influence ANXA2			[39]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	243
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 243 has the potential to affect its expression or activity.
PTM Phenomenon 23	Have the potential to influence ANXA2			[21]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	277
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 277 has the potential to affect its expression or activity.
PTM Phenomenon 24	Have the potential to influence ANXA2			[40]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	296
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 296 has the potential to affect its expression or activity.
PTM Phenomenon 25	Have the potential to influence ANXA2			[41]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	305
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 305 has the potential to affect its expression or activity.
PTM Phenomenon 26	Have the potential to influence ANXA2			[37] , [42]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	314
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Serine 314 has the potential to affect its expression or activity.
Threonine	16 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[24] , [26]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	3
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 3 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[24] , [43]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	19
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 19 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[44] , [45]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	31
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 31 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	44
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 44 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA2			[19] , [20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	48
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 48 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA2			[46]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	55
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 55 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	61
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 61 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	79
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 79 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ANXA2			[30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	97
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 97 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ANXA2			[47]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	105
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 105 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ANXA2			[34] , [48]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	123
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 123 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ANXA2			[49]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	136
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 136 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ANXA2			[32] , [50]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	153
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 153 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ANXA2			[28]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	163
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 163 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ANXA2			[30]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	218
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 218 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ANXA2			[51]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	323
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Threonine 323 has the potential to affect its expression or activity.
Tyrosine	20 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Rearrangement of dynamic actin structures			[52]
Role of PTM	Protein Stability
Affected Drug/Substrate	Calcium-dependent lipid	Results for Drug	Affecting the inward transport of calcium-dependent lipid
Modified Residue	Tyrosine	Modified Location	23
Modified State	Tyrosine to Glutamicacid mutation
Related Enzyme	Tyrosine-protein kinase CSK (CSK)
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Experimental Method	Co-Immunoprecipitation
Detailed Description	Removal of the Phosphorylation at ANXA2 Tyrosine 23 (i.e. Tyrosine to Glutamicacid mutation) have been reported to enable the rearrangement of its dynamic actin structures.
PTM Phenomenon 2	Affecting the surface membrane expression of ANXA2			[53] , [54]
Role of PTM	Surface Expression Modulation
Modified Residue	Tyrosine	Modified Location	24
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 24 have been reported to affect its surface membrane expression.
PTM Phenomenon 3	Have the potential to influence ANXA2			[55]
Role of PTM	Potential impacts
Modified Residue	Tyrosine
Studied Phenotype	Hepatocellular carcinoma [ICD11: 2C12.02]
Experimental Material(s)	Chinese hamster ovary (CHO) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[56] , [57]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	30
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 30 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA2			[58] , [59]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	75
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 75 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA2			[58] , [60]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	109
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 109 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA2			[49] , [61]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	147
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 147 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ANXA2			[49] , [61]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	151
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 151 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ANXA2			[56] , [62]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	188
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 188 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ANXA2			[29] , [63]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	199
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 199 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ANXA2			[64] , [65]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	232
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 232 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ANXA2			[58] , [66]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	235
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 235 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ANXA2			[27] , [56]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	238
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 238 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ANXA2			[67]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	269
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 269 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ANXA2			[21] , [68]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	275
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 275 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ANXA2			[30] , [37]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	316
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 316 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence ANXA2			[57] , [63]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	317
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 317 has the potential to affect its expression or activity.
PTM Phenomenon 18	Have the potential to influence ANXA2			[57] , [69]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	318
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 318 has the potential to affect its expression or activity.
PTM Phenomenon 19	Have the potential to influence ANXA2			[58]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	327
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 327 has the potential to affect its expression or activity.
PTM Phenomenon 20	Have the potential to influence ANXA2			[40] , [58]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	333
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 Tyrosine 333 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[20]
Role of PTM	Potential impacts
Modified Location	351
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at ANXA2 351 has the potential to affect its expression or activity.
S-glutathionylation
Cystine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[70]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-glutathionylation (-SSG) at ANXA2 Cystine 9 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[70]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-glutathionylation (-SSG) at ANXA2 Cystine 133 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[70]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	262
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-glutathionylation (-SSG) at ANXA2 Cystine 262 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[70]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	335
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-glutathionylation (-SSG) at ANXA2 Cystine 335 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[71]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at ANXA2 Cystine 9 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[72] , [73]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation at ANXA2 Cystine 133 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[73]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	262
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation at ANXA2 Cystine 262 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[74]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	335
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at ANXA2 Cystine 335 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[75]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ANXA2 Cystine 9 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[75] , [76]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ANXA2 Cystine 133 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[75]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	335
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at ANXA2 Cystine 335 has the potential to affect its expression or activity.
S-sulfhydration
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[77]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	9
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-sulfhydration (-SSH) at ANXA2 Cystine 9 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[78]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-sulfhydration (-SSH) at ANXA2 Cystine 133 has the potential to affect its expression or activity.
Succinylation
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	119
Experimental Method	Co-Immunoprecipitation
Detailed Description	Succinylation at ANXA2 Lysine 119 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	176
Experimental Method	Co-Immunoprecipitation
Detailed Description	Succinylation at ANXA2 Lysine 176 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	227
Experimental Method	Co-Immunoprecipitation
Detailed Description	Succinylation at ANXA2 Lysine 227 has the potential to affect its expression or activity.
Sulfoxidation
Methionine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[79]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	118
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at ANXA2 Methionine 118 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[80] , [81]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	171
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at ANXA2 Methionine 171 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[80]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	217
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at ANXA2 Methionine 217 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[80]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	240
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sulfoxidation at ANXA2 Methionine 240 has the potential to affect its expression or activity.
SUMOylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[82]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	49
Experimental Method	Co-Immunoprecipitation
Detailed Description	Sumoylation at ANXA2 Lysine 49 has the potential to affect its expression or activity.
Ubiquitination
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	175
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Alanine 175 has the potential to affect its expression or activity.
Arginine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1] , [83]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	245
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Arginine 245 has the potential to affect its expression or activity.
Asparticacid	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1] , [83]
Role of PTM	Potential impacts
Modified Residue	Asparticacid	Modified Location	166
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Asparticacid 166 has the potential to affect its expression or activity.
Glutamine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Glutamine	Modified Location	320
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Glutamine 320 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	122
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Glycine 122 has the potential to affect its expression or activity.
Leucine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	170
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Leucine 170 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[1] , [83]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	331
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Leucine 331 has the potential to affect its expression or activity.
Lysine	16 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence ANXA2			[84] , [85]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	28
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 28 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence ANXA2			[84]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	47
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 47 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence ANXA2			[84]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	49
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 49 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence ANXA2			[84] , [85]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	104
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 104 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence ANXA2			[1] , [84]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	115
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 115 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence ANXA2			[83]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	148
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 148 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	152
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 152 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence ANXA2			[1] , [84]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	157
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 157 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence ANXA2			[84]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	204
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 204 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence ANXA2			[84] , [85]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	212
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 212 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence ANXA2			[83]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	227
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 227 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence ANXA2			[84] , [85]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	266
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 266 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence ANXA2			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	279
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 279 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence ANXA2			[1] , [84]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	302
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 302 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence ANXA2			[83]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	313
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 313 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence ANXA2			[86]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	324
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at ANXA2 Lysine 324 has the potential to affect its expression or activity.

References
1	Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40.
2	Lysine Acetylation and Succinylation in HeLa Cells and their Essential Roles in Response to UV-induced Stress. Sci Rep. 2016 Jul 25;6:30212.
3	System-Wide Analysis of Protein Acetylation and Ubiquitination Reveals a Diversified Regulation in Human Cancer Cells. Biomolecules. 2020 Mar 6;10(3):411.
4	Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response. Mol Cell. 2015 Sep 3;59(5):867-81.
5	Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. Cell Rep. 2013 Aug 29;4(4):842-51.
6	Persistent human Borna disease virus infection modifies the acetylome of human oligodendroglia cells towards higher energy and transporter levels. Virology. 2015 Nov;485:58-78.
7	Global-scale profiling of differential expressed lysine acetylated proteins in colorectal cancer tumors and paired liver metastases. J Proteomics. 2016 Jun 16;142:24-32.
8	Proteomic investigations of lysine acetylation identify diverse substrates of mitochondrial deacetylase sirt3. PLoS One. 2012;7(12):e50545.
9	Monoclonal antibody cocktail as an enrichment tool for acetylome analysis. Anal Chem. 2011 May 15;83(10):3623-6.
10	Suberoylanilide hydroxamic acid treatment reveals crosstalks among proteome, ubiquitylome and acetylome in non-small cell lung cancer A549 cell line. Sci Rep. 2015 Mar 31;5:9520.
11	RedoxDB--a curated database for experimentally verified protein oxidative modification. Bioinformatics. 2012 Oct 1;28(19):2551-2.
12	Regulation of annexin A2 by reversible glutathionylation. J Biol Chem. 2004 Feb 27;279(9):7740-50.
13	In vivo tagging and characterization of S-glutathionylated proteins by a chemoenzymatic method. Angew Chem Int Ed Engl. 2012 Jun 11;51(24):5871-5.
14	Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
15	Next-generation unnatural monosaccharides reveal that ESRRB O-GlcNAcylation regulates pluripotency of mouse embryonic stem cells. Nat Commun. 2019 Sep 6;10(1):4065.
16	O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma. Mol Oncol. 2019 Feb;13(2):338-357.
17	Comparative proteomic analysis of cysteine oxidation in colorectal cancer patients. Mol Cells. 2013 Jun;35(6):533-42.
18	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
19	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
20	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
21	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
22	Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5860-5.
23	Protein phosphorylation and its role in the regulation of Annexin A2 function. Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2515-2529.
24	Quantitative Phosphoproteome Analysis of Clostridioides difficile Toxin B Treated Human Epithelial Cells. Front Microbiol. 2018 Dec 17;9:3083.
25	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
26	iTRAQ-based phosphoproteomic analysis reveals host cell's specific responses to Toxoplasma gondii at the phases of invasion and prior to egress. Biochim Biophys Acta Proteins Proteom. 2019 Mar;1867(3):202-212.
27	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
28	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
29	Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome. Sci Rep. 2017 Jul 3;7(1):4513.
30	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
31	Prognostic significance of imaging features of peritumoral adipose tissue in FDG PET/CT of patients with colorectal cancer. Eur J Radiol. 2021 Dec;145:110047.
32	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
33	Combination of multistep IMAC enrichment with high-pH reverse phase separation for in-depth phosphoproteomic profiling. J Proteome Res. 2013 Sep 6;12(9):4176-86.
34	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
35	Proteotype profiling unmasks a viral signalling network essential for poxvirus assembly and transcriptional competence. Nat Microbiol. 2018 May;3(5):588-599.
36	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
37	Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab. Neoplasia. 2018 Jul;20(7):668-677.
38	Primary renal primitive neuroectodermal tumour causing Budd-Chiari syndrome: a rare case report. BJR Case Rep. 2016 Nov 2;2(4):20150184.
39	Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response. Mol Cell Proteomics. 2017 May;16(5):891-910.
40	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
41	Systems-level overview of host protein phosphorylation during Shigella flexneri infection revealed by phosphoproteomics. Mol Cell Proteomics. 2013 Oct;12(10):2952-68.
42	Physical activity in patients undergoing automated and continuous ambulatory peritoneal dialysis: A cross-sectional study. Saudi J Kidney Dis Transpl. 2019 Jan-Feb;30(1):265-267.
43	The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020 Aug 6;182(3):685-712.e19.
44	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
45	Hepatitis C virus-induced glomerular disease and posterior reversible encephalopathy syndrome after liver transplant: Case report and literature review. Saudi J Kidney Dis Transpl. 2019 Jan-Feb;30(1):239-249.
46	Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.
47	Improved Method for Determining Absolute Phosphorylation Stoichiometry Using Bayesian Statistics and Isobaric Labeling. J Proteome Res. 2017 Nov 3;16(11):4217-4226.
48	Phosphoproteomic analysis reveals PAK2 as a therapeutic target for lapatinib resistance in HER2-positive breast cancer cells. Biochem Biophys Res Commun. 2018 Oct 20;505(1):187-193.
49	Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
50	Rapid combinatorial ERLIC-SCX solid-phase extraction for in-depth phosphoproteome analysis. J Proteome Res. 2013 Dec 6;12(12):5989-95.
51	Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection. J Proteomics. 2017 Jun 6;162:99-107.
52	Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells. Breast Cancer Res Treat. 2017 Jul;164(2):327-340.
53	An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem. 2004 Oct 15;279(42):43411-8.
54	The protein-tyrosine kinase substrate p36 is also a substrate for protein kinase C in vitro and in vivo. Mol Cell Biol. 1986 Jul;6(7):2738-44.
55	Effect of ethanol on p36 protein kinase substrate and insulin receptor substrate 1 expression and tyrosyl phosphorylation in human hepatocellular carcinoma cells. Alcohol Clin Exp Res. 1995 Apr;19(2):441-6.
56	Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma. Nat Commun. 2018 Nov 21;9(1):4904.
57	Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis. Cell Metab. 2019 Jan 8;29(1):141-155.e9.
58	Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters. J Proteome Res. 2017 Feb 3;16(2):1077-1086.
59	Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One. 2011 Jan 6;6(1):e15640.
60	Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling. Mol Cell Proteomics. 2016 Aug;15(8):2671-85.
61	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
62	Comparative phosphoproteomic analysis reveals signaling networks regulating monopolar and bipolar cytokinesis. Sci Rep. 2018 Feb 2;8(1):2269.
63	Phosphoproteomics Analysis Identifies Novel Candidate Substrates of the Nonreceptor Tyrosine Kinase, S rc- r elated Kinase Lacking C-terminal Regulatory Tyrosine and N-terminal M yristoylation S ites (SRMS). Mol Cell Proteomics. 2018 May;17(5):925-947.
64	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
65	Hymen Tearing in the Treatment of Vaginal Agenesis: Implications on Women in Turkey. J Transcult Nurs. 2014 Jul;25(3):303-6.
66	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
67	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ANXA2_HUMAN)
68	Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways. Oncotarget. 2015 Oct 6;6(30):29143-60.
69	Analysis of Cellular Tyrosine Phosphorylation via Chemical Rescue of Conditionally Active Abl Kinase. Biochemistry. 2018 Feb 27;57(8):1390-1398.
70	dbGSH: a database of S-glutathionylation. Bioinformatics. 2014 Aug 15;30(16):2386-8.
71	Nitrosothiol-Trapping-Based Proteomic Analysis of S-Nitrosylation in Human Lung Carcinoma Cells. PLoS One. 2017 Jan 12;12(1):e0169862.
72	Predict and analyze S-nitrosylation modification sites with the mRMR and IFS approaches. J Proteomics. 2012 Feb 16;75(5):1654-65.
73	Decoding the s-nitrosoproteomic atlas in individualized human colorectal cancer tissues using a label-free quantitation strategy. J Proteome Res. 2014 Nov 7;13(11):4942-58.
74	Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection. Circ Res. 2015 Oct 23;117(10):846-57.
75	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
76	Identification of Palmitoylated Transitional Endoplasmic Reticulum ATPase by Proteomic Technique and Pan Antipalmitoylation Antibody. J Proteome Res. 2016 Mar 4;15(3):956-62.
77	Site-Specific Quantification of Persulfidome by Combining an Isotope-Coded Affinity Tag with Strong Cation-Exchange-Based Fractionation. Anal Chem. 2019 Dec 3;91(23):14860-14864.
78	Direct Proteomic Mapping of Cysteine Persulfidation. Antioxid Redox Signal. 2020 Nov 20;33(15):1061-1076.
79	Redox-based reagents for chemoselective methionine bioconjugation. Science. 2017 Feb 10;355(6325):597-602.
80	Global analysis of methionine oxidation provides a census of folding stabilities for the human proteome. Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6081-6090.
81	Quantitative Analysis of in Vivo Methionine Oxidation of the Human Proteome. J Proteome Res. 2020 Feb 7;19(2):624-633.
82	Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli. Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12432-7.
83	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
84	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
85	Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol Cell Proteomics. 2011 Mar;10(3):M110.003590.
86	New findings on essential amino acids. Cesk Fysiol. 1990;39(1):13-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence